Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1544278

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1544278

Europe Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Europe Genomics In Cancer Care Market would witness market growth of 15.5% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,939.1 million by 2031. The UK market is exhibiting a CAGR of 14.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 16.4% during (2024 - 2031).

Genomic information allows for the personalization of chemotherapy regimens based on the genetic profile of the patient and the tumor. By identifying genetic variations that affect drug metabolism and efficacy, clinicians can tailor chemotherapy protocols to improve treatment effectiveness and reduce adverse effects, ensuring that each patient receives the most appropriate drugs.

Additionally, adoption of genomics in cancer care has significantly transformed the oncology landscape, driven personalized treatment approaches, and improved patient outcomes. Genomics is increasingly integrated into standard clinical practice as part of routine cancer care.

The high cancer rates in Europe lead to increased government funding and support for cancer research programs. European governments allocate more resources towards genomic research initiatives to understand cancer genomics and develop new treatments. Among the EU countries, the share of deaths from cancer in the total number of deaths in 2021 reached or exceeded 26.0 % in Denmark (28.2 %), Ireland (27.7 %), Slovenia (27.1 %) and the Netherlands (26.6 %). This share peaked at 30.7 % among males in Slovenia, followed by 29.5 % in Denmark.

Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation (Beckman Coulter, Inc.)
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • GE HealthCare Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Revvity, Inc.
  • Eurofins Scientific SE
  • Hologic, Inc.

Europe Genomics In Cancer Care Market Report Segmentation

By Application

  • Diagnostics
  • Personalized Medicine
  • Drug Discovery & Development
  • Research

By Product

  • Instruments
  • Consumables
  • Services

By Technology

  • PCR
  • Genome Sequencing
  • Microarrays
  • Nuclei Acid Extraction & Purification
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Genomics In Cancer Care Market, by Application
    • 1.4.2 Europe Genomics In Cancer Care Market, by Product
    • 1.4.3 Europe Genomics In Cancer Care Market, by Technology
    • 1.4.4 Europe Genomics In Cancer Care Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
  • 4.3 Market Share Analysis, 2023
  • 4.4 Top Winning Strategies
    • 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
    • 4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan - 2023, Jan) Leading Players
  • 4.5 Porter Five Forces Analysis

Chapter 5. Europe Genomics In Cancer Care Market by Application

  • 5.1 Europe Diagnostics Market by Country
  • 5.2 Europe Personalized Medicine Market by Country
  • 5.3 Europe Drug Discovery & Development Market by Country
  • 5.4 Europe Research Market by Country

Chapter 6. Europe Genomics In Cancer Care Market by Product

  • 6.1 Europe Instruments Market by Country
  • 6.2 Europe Consumables Market by Country
  • 6.3 Europe Services Market by Country

Chapter 7. Europe Genomics In Cancer Care Market by Technology

  • 7.1 Europe PCR Market by Country
  • 7.2 Europe Genome Sequencing Market by Country
  • 7.3 Europe Microarrays Market by Country
  • 7.4 Europe Nuclei Acid Extraction & Purification Market by Country
  • 7.5 Europe Others Market by Country

Chapter 8. Europe Genomics In Cancer Care Market by Country

  • 8.1 Germany Genomics In Cancer Care Market
    • 8.1.1 Germany Genomics In Cancer Care Market by Application
    • 8.1.2 Germany Genomics In Cancer Care Market by Product
    • 8.1.3 Germany Genomics In Cancer Care Market by Technology
  • 8.2 UK Genomics In Cancer Care Market
    • 8.2.1 UK Genomics In Cancer Care Market by Application
    • 8.2.2 UK Genomics In Cancer Care Market by Product
    • 8.2.3 UK Genomics In Cancer Care Market by Technology
  • 8.3 France Genomics In Cancer Care Market
    • 8.3.1 France Genomics In Cancer Care Market by Application
    • 8.3.2 France Genomics In Cancer Care Market by Product
    • 8.3.3 France Genomics In Cancer Care Market by Technology
  • 8.4 Russia Genomics In Cancer Care Market
    • 8.4.1 Russia Genomics In Cancer Care Market by Application
    • 8.4.2 Russia Genomics In Cancer Care Market by Product
    • 8.4.3 Russia Genomics In Cancer Care Market by Technology
  • 8.5 Spain Genomics In Cancer Care Market
    • 8.5.1 Spain Genomics In Cancer Care Market by Application
    • 8.5.2 Spain Genomics In Cancer Care Market by Product
    • 8.5.3 Spain Genomics In Cancer Care Market by Technology
  • 8.6 Italy Genomics In Cancer Care Market
    • 8.6.1 Italy Genomics In Cancer Care Market by Application
    • 8.6.2 Italy Genomics In Cancer Care Market by Product
    • 8.6.3 Italy Genomics In Cancer Care Market by Technology
  • 8.7 Rest of Europe Genomics In Cancer Care Market
    • 8.7.1 Rest of Europe Genomics In Cancer Care Market by Application
    • 8.7.2 Rest of Europe Genomics In Cancer Care Market by Product
    • 8.7.3 Rest of Europe Genomics In Cancer Care Market by Technology

Chapter 9. Company Profiles

  • 9.1 Agilent Technologies, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 F. Hoffmann-La Roche Ltd.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
    • 9.2.6 SWOT Analysis
  • 9.3 Danaher Corporation (Beckman Coulter, Inc.)
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
    • 9.3.6 SWOT Analysis
  • 9.4 Abbott Laboratories
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 SWOT Analysis
  • 9.5 Bio-Rad laboratories, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Product Launches and Product Expansions:
    • 9.5.6 SWOT Analysis
  • 9.6 GE HealthCare Technologies, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expenses
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
    • 9.6.6 SWOT Analysis
  • 9.7 Quest Diagnostics Incorporated
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental Analysis
    • 9.7.4 SWOT Analysis
  • 9.8 Revvity, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Acquisition and Mergers:
    • 9.8.6 SWOT Analysis
  • 9.9 Eurofins Scientific SE
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 SWOT Analysis
  • 9.10. Hologic, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 Recent strategies and developments:
      • 9.10.5.1 Acquisition and Mergers:
    • 9.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Europe Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 2 Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Genomics In Cancer Care Market
  • TABLE 4 Product Launches And Product Expansions- Genomics In Cancer Care Market
  • TABLE 5 Acquisition and Mergers- Genomics In Cancer Care Market
  • TABLE 6 Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 7 Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 8 Europe Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 9 Europe Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 10 Europe Personalized Medicine Market by Country, 2020 - 2023, USD Million
  • TABLE 11 Europe Personalized Medicine Market by Country, 2024 - 2031, USD Million
  • TABLE 12 Europe Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
  • TABLE 13 Europe Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
  • TABLE 14 Europe Research Market by Country, 2020 - 2023, USD Million
  • TABLE 15 Europe Research Market by Country, 2024 - 2031, USD Million
  • TABLE 16 Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 17 Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 18 Europe Instruments Market by Country, 2020 - 2023, USD Million
  • TABLE 19 Europe Instruments Market by Country, 2024 - 2031, USD Million
  • TABLE 20 Europe Consumables Market by Country, 2020 - 2023, USD Million
  • TABLE 21 Europe Consumables Market by Country, 2024 - 2031, USD Million
  • TABLE 22 Europe Services Market by Country, 2020 - 2023, USD Million
  • TABLE 23 Europe Services Market by Country, 2024 - 2031, USD Million
  • TABLE 24 Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 25 Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 26 Europe PCR Market by Country, 2020 - 2023, USD Million
  • TABLE 27 Europe PCR Market by Country, 2024 - 2031, USD Million
  • TABLE 28 Europe Genome Sequencing Market by Country, 2020 - 2023, USD Million
  • TABLE 29 Europe Genome Sequencing Market by Country, 2024 - 2031, USD Million
  • TABLE 30 Europe Microarrays Market by Country, 2020 - 2023, USD Million
  • TABLE 31 Europe Microarrays Market by Country, 2024 - 2031, USD Million
  • TABLE 32 Europe Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
  • TABLE 33 Europe Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
  • TABLE 34 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 35 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 36 Europe Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
  • TABLE 37 Europe Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
  • TABLE 38 Germany Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 39 Germany Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 40 Germany Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 41 Germany Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 42 Germany Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 43 Germany Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 44 Germany Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 45 Germany Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 46 UK Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 47 UK Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 48 UK Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 49 UK Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 50 UK Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 51 UK Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 52 UK Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 53 UK Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 54 France Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 55 France Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 56 France Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 57 France Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 58 France Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 59 France Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 60 France Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 61 France Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 62 Russia Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 63 Russia Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 64 Russia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 65 Russia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 66 Russia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 67 Russia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 68 Russia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 69 Russia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 70 Spain Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 71 Spain Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 72 Spain Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 73 Spain Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 74 Spain Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 75 Spain Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 76 Spain Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 77 Spain Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 78 Italy Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 79 Italy Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 80 Italy Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 81 Italy Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 82 Italy Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 83 Italy Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 84 Italy Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 85 Italy Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 86 Rest of Europe Genomics In Cancer Care Market, 2020 - 2023, USD Million
  • TABLE 87 Rest of Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
  • TABLE 88 Rest of Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
  • TABLE 89 Rest of Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
  • TABLE 90 Rest of Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
  • TABLE 91 Rest of Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
  • TABLE 92 Rest of Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
  • TABLE 93 Rest of Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
  • TABLE 94 key Information - Agilent Technologies, Inc.
  • TABLE 95 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 96 Key Information - Danaher Corporation
  • TABLE 97 Key Information - Abbott Laboratories
  • TABLE 98 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 99 Key Information - GE HealthCare Technologies, Inc.
  • TABLE 100 Key information - Quest Diagnostics Incorporated
  • TABLE 101 Key Information - Revvity, Inc.
  • TABLE 102 Key Information - Eurofins Scientific SE
  • TABLE 103 Key Information - Hologic, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!